Glucosamine, a widely used over-the-counter supplement for joint pain, may worsen outcomes in people with Alzheimer’s disease and related dementias, according to new research by neuroscientists from the University of Florida.

University of Florida researchers found glucosamine users with mild cognitive impairment were 25% more likely to progress to dementia in a new study.